1 unchanged sentence
The exhibits listed below are filed or furnished as part of this report.
−Removed: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
−Removed: 2002 (filed herewith).
−Removed: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
−Removed: 2002 (filed herewith).
+Added: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the
+Added: Sarbanes-Oxley Act of 2002 (filed herewith).
+Added: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the
+Added: Sarbanes-Oxley Act of 2002 (filed herewith).
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
13 unchanged sentences
Aquestive Therapeutics, Inc.
−Removed: November 4, 2020
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: November 4, 2020
−Removed: Chief Financial Officer
+Added: Ernest Toth, Jr.
+Added: Ernest Toth, Jr.
+Added: Interim Chief Financial Officer
(Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.